Gentian

Gentiana lutea L. belongs to Gentianaceae, the gentian family, and was published by Linnaeus in Species Plantarum in 1753. Kew’s Plants of the World Online gives its native range as the mountains of Europe to western Türkiye: Portugal, Spain, France, Corsica, Sardinia, Switzerland, Germany, Austria, Italy, the north-western Balkans, Albania, Greece, Bulgaria, Romania, Ukraine, and Türkiye, with an introduced population in the former Czechoslovakia. Kew accepts several infraspecific taxa, including subsp. lutea across most of that range, subsp. symphyandra from north-western Italy and the south-eastern Alps through the Balkans to Türkiye, subsp. vardjanii in Slovenia, subsp. montserratii, and the orange-flowered var. aurantiaca. In the Cantabrian Mountains of northern Spain, Guitián and colleagues (PeerJ 2017) describe orange-flowered populations in the west and yellow-flowered ones in the east, with intermediate shades between. Mrs Grieve’s A Modern Herbal (1931) notes that the species does not reach northern Europe or the British Isles. Other gentians are not interchangeable with it in European regulation: EMA notes that the Chinese drug long dan comes from G. manshurica, G. scabra, G. triflora, or G. rigescens, and Grieve lists G. purpurea, G. pannonica, and G. punctata as European species once used in its place.

Yellow gentian is a stout, unbranched plant 1 to 2 meters tall. EMA’s assessment report describes broad, lance-shaped to elliptic leaves 10 to 30 cm long and 4 to 12 cm wide, and Grieve adds that they grow in opposite pairs, have five prominent veins underneath, and clasp the stem higher up. In summer, clusters of yellow flowers form in the axils of the upper leaf pairs, each corolla split almost to the base into five to seven narrow, star-like lobes. The fruit is an egg-shaped capsule holding winged seeds 3 to 4 mm long, and the plant needs pollinators, mainly bumblebees, to set seed (Guitián and colleagues). Below ground, EMA notes, the main root can exceed a meter in length and weigh up to 7 kg fresh. Growth is slow: the Dutch Botanical Gardens Association says that in mountain pastures a plant may take 10 years to flower for the first time and can live for 60 years, producing up to 10,000 wind-carried seeds a year, while Grieve reported that garden seedlings reached flowering size in about three. Livestock matter. In north-western Spain, Sobral and colleagues (PeerJ 2016) found that plants grazed by cattle and horses set about 1,269 seeds on average, against 5,005 for ungrazed plants.

The medicinal part is the root and rhizome. The European Pharmacopoeia, quoted by EMA, defines gentian root as the dried, fragmented underground organs, with a characteristic smell and a strong, persistent bitter taste. EMA’s assessment report puts bitter constituents at 2–8%, mostly in the outer cortex, led by gentiopicroside (PubChem CID 88708, C16H20O9) with much smaller amounts of amarogentin (CID 115149, C29H30O13), at 0.025–0.4%. It gives a bitterness value of 12,000 for gentiopicroside and 58 million for amarogentin, and Germany’s Commission E required the root to have a bitterness value of at least 10,000. Bitter content rises with altitude, varies with root age, and peaks in spring, when sugars are lowest. Up to 1% xanthones, such as gentisin (CID 5281636, C14H10O5) and isogentisin, give the root its yellow color, and 30–55% is carbohydrates, including gentianose and the bitter disaccharide gentiobiose. Roots must be dried promptly, because fermentation changes the color and sharply reduces the extract yield (EMA). Quality problems are old: Grieve records gentian root mixed with belladonna, aconite, orris, and white hellebore, and powdered root bulked out with ground almond shells and olive stones. Fiorito and colleagues (Journal of Natural Products 2022) have proposed the leaves as an alternative source of the bitter compounds, to spare wild roots.

Gentian’s name preserves an ancient story. In his Natural History, written in the first century AD, Pliny the Elder said gentian was first discovered by Gentius, king of Illyria, and that the Illyrian plant was the finest. He described a leaf like an ash leaf but as large as a lettuce, a hollow stem as thick as a thumb and up to three cubits tall, and a dark, flexible root, and he noted that it grew most abundantly in damp places at the foot of the Alps. The root and juice were the parts used, and Pliny warned that it should never be taken by pregnant women. Grieve dates Gentius to 180–167 BC and says Dioscorides also credited him with discovering the plant’s medicinal value. She adds that in the Middle Ages gentian was commonly used as an antidote to poison, that before hops were introduced it was used with other bitter herbs in brewing, and that the English herbalist John Gerard grew it in his London garden from plants sent by a French physician in Burgundy.

By the nineteenth century gentian was the standard bitter tonic of Western pharmacy. King’s American Dispensatory (1898) defined the official US Pharmacopeia drug as the root of Gentiana lutea, imported through Le Havre and Marseille, and called it a powerful tonic that improves the appetite and strengthens digestion. It recommended gentian for dyspepsia and for convalescence after long fevers, when recovery depended on the ability to take in food, as well as for gout, intermittent fevers, and worms. Chemists were isolating its principles: King’s credits Kromayer with first obtaining pure gentiopicrin in 1862, a bitter substance earlier described as gentianin by Henry and Caventou in 1821. Grieve (1931) called gentian one of the most useful bitter vegetable tonics and recorded a home tincture of gentian root, dried orange peel, and cardamom in brandy for restoring appetite, along with the gentian and sweet-flag Stockton bitters of English country remedies. She also noted that in the eighteenth century gentian wine was drunk as an aperitif before dinner, and EMA cites the German herbalist Madaus (1938) on its use as a bitter stomachic and for intermittent fevers.

The root’s bitterness built an industry. King’s described a prized Swiss liquor made by fermenting gentian root with sugar and yeast and then distilling it, and quoted the pharmacognosist Flückiger (1891) that as a result the plant had almost disappeared from parts of Switzerland. Grieve recorded the same distilled spirit in Germany and Switzerland. In France, the company behind Suze says Fernand Moureaux created the bright yellow aperitif in 1889, building it on gentian root instead of wine, and Pernod Ricard says it is made from cultivated and wild gentian, partly from the Auvergne. Angostura aromatic bitters lists gentian on its US label. Medical regulation followed a separate track. Germany’s Commission E published a gentian monograph in 1985, revised in 1990, for loss of appetite, fullness, and flatulence (EMA), and a German dry extract authorized in 2003 was withdrawn in 2009. EMA adopted a European monograph in November 2009 and revised it in November 2018. In a periodic review completed in March 2025, EMA’s assessors concluded that the new data did not justify changing the monograph, and noted that the registration of one single-herb gentian tincture had expired in 2022.

The classic explanation is a reflex triggered by taste. According to Germany’s Commission E, as summarized by EMA, the bitter substances in gentian excite the taste receptors and so increase saliva and gastric secretion, which is why the root was regarded as a tonic and not merely a bitter. Modern taste biology has put names to those receptors. Humans have about 25 bitter-taste receptors, called TAS2Rs (Meyerhof and colleagues, Chemical Senses 2010), and Wölfle and colleagues (Mediators of Inflammation 2015) list seven that amarogentin activates: TAS2R1, TAS2R4, TAS2R39, TAS2R43, TAS2R46, TAS2R47, and TAS2R50. Bitter receptors also occur in the lining of the gut in animals, and researchers have proposed that activating them there could influence secretion, motility, and absorption (EMA, citing Rozengurt and Sternini). Animal and cell studies point the same way. In dogs, bitters placed on the tongue increased gastric juice (Borissow 1903); in rats, gentian extract put into the stomach increased gastric secretion in a dose-dependent way (Leslie 1978); and in cultured rat stomach cells, a water extract raised a marker of acid production 1.7-fold at 100 µg/ml, while an artichoke extract had no such effect (Gebhardt 1997, all cited by EMA).

Human evidence for the mechanism is real but thin. EMA summarizes a 1938 study in which X-rays of five healthy volunteers showed thicker stomach lining and more mucus after gentian extract, two studies from 1966 and 1967 in which an alcoholic gentian extract increased saliva and gastric juice, and a 1981 trial in 24 healthy volunteers in which a 2% gentian tincture raised saliva for 30 minutes about as much as citric acid. McMullen and colleagues (Journal of Ethnopharmacology 2014) added a twist. When healthy volunteers drank 100 ml of water flavored with 500 or 1,500 mg of gentian, their blood vessels tightened and the heart pumped less blood per beat within 5 to 10 minutes, a reflex the authors attributed to the nervous system’s response to taste, but 1,000 mg swallowed in capsules had no such effect. In a 2015 review in Evidence-Based Complementary and Alternative Medicine, the same group argued that gentian facilitates rather than stimulates digestion. EMA, by contrast, read the observational data as evidence of a local effect in the stomach that supports capsules too. Neither view has been tested against symptoms in a controlled trial.

Many other effects have been reported in the laboratory. Hydroethanolic root extracts relaxed spontaneous and drug-induced contractions of isolated rat intestine, mainly by opening potassium channels (Kitić and colleagues, Plants 2024). In a screening study against 15 strains of Helicobacter pylori, a methanol root extract had a minimum inhibitory concentration of 100 µg/ml, gentiopicroside limited chemically induced liver injury in mice at 30–60 mg/kg a day, and root extracts showed antioxidant and antifungal activity (all summarized by EMA). Amarogentin dampened inflammatory signals in human mast cells and skin cells in culture through a bitter-receptor pathway (Wölfle and colleagues). A 2023 systematic review by Ponticelli and colleagues (Phytochemistry) catalogs promising activity against oxidative stress, microbes, inflammation, obesity, and atherosclerosis, mostly in cells and animals. EMA concluded that these effects do not seem to support the traditional uses. Absorption is also poorly understood: there are no pharmacokinetic data for gentian preparations, and in rats the bioavailability of gentiopicroside varied markedly with the preparation, while human gut bacteria convert it into several metabolites (EMA, citing Wang 2007 and El-Sedawy 1989).

Loss of appetite and mild indigestion are gentian’s officially recognized uses in Europe. EMA’s 2018 monograph accepts the cut root as a tea, a dry extract, a liquid extract, and a tincture as traditional herbal medicines for adults, for two indications: temporary loss of appetite, and mild dyspeptic or gastrointestinal disorders. Both are “exclusively based upon long-standing use,” and anyone whose symptoms last more than two weeks is told to see a doctor. Germany’s Commission E listed digestive disorders such as loss of appetite, fullness, and flatulence, and ESCOP, the European scientific cooperative on phytotherapy, cited loss of appetite after illness and dyspeptic complaints (EMA). EMA’s assessors were candid about the evidence: clinical pharmacological data meeting current standards do not exist, controlled clinical trials have not been performed, and the plausibility of efficacy rests on traditional use and experimental data. That puts gentian in the same evidence tier as most classic digestive teas, and below herbs such as artichoke leaf or peppermint oil that have at least one positive placebo-controlled trial.

The closest thing to a clinical study is an open, uncontrolled observational study by Wegner (1997), summarized by EMA. Doctors treated 205 people with assorted indigestion symptoms, including heartburn, nausea, stomach ache, loss of appetite, constipation, and wind, with capsules of a gentian root dry extract two to three times a day for 15 days, an average of 576 mg of extract daily. Most improved within five days, average symptom improvement reached 68%, and doctors rated the result excellent in 31% and good in 55%. With no comparison group, those numbers cannot be separated from natural recovery and expectation, and EMA concluded that the study only supports the plausibility of using the extract. The only controlled trial involving gentian tested it in combination: Borgia and colleagues (1981) randomized 80 patients with mild digestive complaints into four groups of 20, and a complete preparation of rhubarb, cascara, boldo, and gentian beat both placebo and two-herb pairs, one of which paired gentian with rhubarb (EMA). Gentian has never been tested against placebo on its own.

Gentian is a staple of multi-herb bitters, and some of these have been studied, though the results cannot be credited to gentian. One herbal Amara extract combines gentian with wormwood, centaury, chicory, juniper, yarrow, masterwort, sage, and dandelion; in guinea pig stomach tissue the mixture relaxed muscle through a muscarinic receptor, but juniper, masterwort, and sage, not gentian, carried that activity (Piqué-Borràs and colleagues, Neurogastroenterology and Motility 2025). Bitters are not only used for digestion. In a 2018–2019 prescription database from Klinik Arlesheim, a Swiss integrative hospital, gentian root accounted for 2,244 prescriptions, the second most common single-herb bitter, and bitter preparations overall were prescribed most often in psychiatry and oncology for anxiety, stress, and stress-related nausea (Nicolay and colleagues, BMC Complementary Medicine and Therapies 2026). That describes a prescribing culture, not proof of benefit. Curiously, bitters are also marketed for the opposite of appetite stimulation: in a three-month placebo-controlled trial that recruited 120 overweight or obese adults on a calorie-restricted diet (92 completed), a capsule of cinchona bark, chicory, and gentian root led to more weight loss than placebo (Schiano and colleagues, International Journal of Molecular Sciences 2024).

BNO 1016 is gentian’s best-tested setting. Sold as Sinupret extract, it is a dry extract of gentian root, primula (cowslip) flower, sorrel herb, elder flower, and verbena herb in the ratio 1:3:3:3:3. In the ARhiSi-2 trial, Jund and colleagues (Rhinology 2012) treated adults with acute viral rhinosinusitis, the common post-cold sinus infection, with BNO 1016 or placebo tablets for 15 days; symptoms eased about two days sooner with the extract, the number needed to treat for one extra cure was 8, and no serious adverse events occurred. A pooled analysis of that trial and an earlier one (Jund and colleagues, Acta Oto-Laryngologica 2015) included 589 adults taking 160 mg three times a day or placebo. By day 14 the five-symptom score, on a scale of 0 to 15, had fallen to 2.47 with BNO 1016 and 3.63 with placebo, and 93.2% versus 85.1% were rated healed or improved; quality of life also favored the extract. One author was employed by the manufacturer, Bionorica, and two were consultants to it. These results belong to the combination, and gentian is its smallest component.

Other claims are early or anecdotal. Wiedermann and colleagues (Wiener klinische Wochenschrift 2026) described a 70-year-old man whose persistent hiccups after anesthesia stopped within a minute of sipping about 20 ml of gentian schnapps, three times in one day; they acknowledged that alcohol or spontaneous recovery could explain it. Laboratory work on gentian extracts for obesity, blood vessels, and inflammation, reviewed by Ponticelli and colleagues, has not been confirmed in human trials of gentian alone. The realistic use of gentian is modest: a small, very bitter dose before meals for an occasional poor appetite or a heavy, slow stomach, used for a week or two. It is not a treatment for ulcers, reflux, gallbladder disease, or unexplained weight loss, all of which deserve a medical diagnosis.

EMA’s 2018 monograph covers four preparations for adults. As a tea, 0.6–2 g of the cut dried root is steeped in 150 ml of boiling water and taken one to three times a day, up to 6 g daily. A dry extract made with 53% ethanol (drug-to-extract ratio 4.5–5.5:1) is taken as 240 mg two or three times a day, a liquid extract (1:1 in 45% ethanol) as 1 g two to four times a day, and a tincture (1 part root to 5 parts 70% ethanol) as 1 ml one to three times a day. For loss of appetite, the liquid preparations are taken half an hour before a meal and the solid dry extract an hour before, to allow time for the capsule or tablet to dissolve. EMA lowered the maximum daily tea dose from 8 g in its 2009 monograph to 6 g, explaining that no reference supported 8 g and that the extreme bitterness would not favor compliance. Labels of alcoholic tinctures and liquid extracts must carry the standard ethanol warning, and EMA advises seeing a doctor if symptoms persist beyond two weeks or worsen.

Gentian products vary more than their labels suggest. Bitter content depends on the season of harvest, the age of the root, and the altitude where it grew, and roots that ferment before drying lose much of their extract (EMA). Most commercial root now comes from cultivation, mainly in Germany and France, because the wild plant is protected (EMA), although Pernod Ricard says Suze uses both cultivated and wild gentian. Wild collection is regulated: gentian is listed in Annex V of the EU Habitats Directive, which allows member states to manage its taking from the wild, and the IUCN’s 2014 European Red List of Medicinal Plants, while rating it Least Concern across Europe, notes unfavorable conservation status in several EU countries and listings on national red lists. The same report describes certification schemes such as the FairWild Standard for sustainable wild harvesting. Gentian is also widely sold in multi-herb bitters and in combination medicines such as Sinupret, which are tested and regulated as separate products.

Practical points: the bitterness is not a flaw to be masked. McMullen and colleagues found reflex effects when gentian was tasted but not when it was swallowed in capsules, so a few drops of tincture in water or a small cup of tea sipped before a meal is the traditional approach, although EMA also accepts capsules. Start at the low end of the dose range; more is not better, and King’s American Dispensatory warned that large doses oppress the stomach and can cause nausea and headache. Stop if heartburn or stomach pain appears. Tinctures and liquid extracts contain alcohol, which matters for anyone avoiding it. Aperitifs, gentian schnapps, and cocktail bitters are alcoholic drinks, not medicines, and their doses of gentian are unknown. Never dig gentian roots yourself, both because wild plants are protected and because roots of poisonous white hellebore have repeatedly ended up in homemade gentian drinks.